|

Temozolomide (TMZ) Clinical Trials

10 actively recruiting trials across 4 locations

Also known as: Temodal

Other6 trials

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Phase 1/2
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/2
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase 2
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/2
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Phase 2
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
Phase 1

La Jolla, California1 trial

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site

Phase 1/2

Aurora, Colorado1 trial

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Children's Hospital Colorado

Phase 2

Chicago, Illinois1 trial

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Ann & Robert H. Lurie Children's Hospital of Chicago

Phase 2

Philadelphia, Pennsylvania1 trial

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Children's Hospital of Philadelphia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.